Drug peptidomics

Schulz-Knappe P, Zucht HD, Schrader M. Differential peptide display. In Gaenschirt D, Harms F, Rohmann S, Schulz-Knappe P, editors. Peptidomics in Drug Development. Aulendorf, Germany Editio Cantor, 2005 33-35. 

Ganshirt, D., Harms, F., Schuiz-Knappe, P. (2005). Peptidomics in Drug Development. Editio Cantor Verlag, Aulendorf. 

Phytochemistry 62,837-849,2003 Nobeli, I., Ponstingl, H., Krissinel, E.B., and Thornton, J.M., A strncture-based anatomy of the E.coli metabolome, J. Mol. Biol. 334, 697-719, 2003 Parsons, L. and Orban, J., Structural genomics and the metabolome combining computational and NMR methods to identify target hgands, Curr. Opin. Drug Discov. Devel. 7, 62-68, 2004 Soloviev, M. and Finch, P, Peptidomics bridging the gap between proteome and metabolome, Proteomics 6, 744-747, 2006. 

Peptidomic research provides access to a huge number of potentially or factually active components which is an invaluable source of peptide drug leads. The first steps in medically oriented peptidomic studies will be discussed. 

---